<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>insulins</title><link>http://www.unboundmedicine.com/medline/ebm/research/insulins</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921965/full_citation/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_</link><description>Cooke CE, Lee HY, Tong YP, et al. <br/><span class="title">Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current medical research and opinion">Curr Med Res Opin 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921965/abstract/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921965/full_citation/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_">Full Citation</a></description></item><item><title>A review of exenatide as adjunctive therapy in patients with type 2 diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920937/full_citation/A_review_of_exenatide_as_adjunctive_therapy_in_patients_with_type_2_diabetes_</link><description>Robles GI, Singh-Franco D <br/><span class="title">A review of exenatide as adjunctive therapy in patients with type 2 diabetes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug design, development and therapy">Drug Des Devel Ther 2009.:219-240.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920937/abstract/A_review_of_exenatide_as_adjunctive_therapy_in_patients_with_type_2_diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920937/full_citation/A_review_of_exenatide_as_adjunctive_therapy_in_patients_with_type_2_diabetes_">Full Citation</a></description></item><item><title>Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19900235/full_citation/Plasma_glucose_and_hypoglycaemia_following_exercise_in_people_with_Type_1_diabetes:_a_comparison_of_three_basal_insulins_</link><description>Arutchelvam V, Heise T, Dellweg S, et al. <br/><span class="title">Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Diabetic medicine : a journal of the British Diabetic Association">Diabet Med 2009 Oct; 26(10):1027-32.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19900235/abstract/Plasma_glucose_and_hypoglycaemia_following_exercise_in_people_with_Type_1_diabetes:_a_comparison_of_three_basal_insulins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19900235/full_citation/Plasma_glucose_and_hypoglycaemia_following_exercise_in_people_with_Type_1_diabetes:_a_comparison_of_three_basal_insulins_">Full Citation</a></description></item><item><title>What's fueling the biotech engine--2008.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19898448/full_citation/What's_fueling_the_biotech_engine__2008_</link><description>Aggarwal S <br/><span class="title">What's fueling the biotech engine--2008. [Journal Article]</span><br/><span class="source" title="Nature biotechnology">Nat Biotechnol 2009 Nov; 27(11):987-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19898448/abstract/What's_fueling_the_biotech_engine__2008_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19898448/full_citation/What's_fueling_the_biotech_engine__2008_">Full Citation</a> | <a href="http://dx.doi.org/10.1038/nbt1109-987">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19898448/What's_fueling_the_biotech_engine__2008_">Find Related Articles</a> </description></item><item><title>Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19895637/full_citation/Mid__and_high_ratio_premix_insulin_analogues:_potential_treatment_options_for_patients_with_type_2_diabetes_in_need_of_greater_postprandial_blood_glucose_control_</link><description>Christiansen JS, Liebl A, Davidson JA, et al. <br/><span class="title">Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control. [JOURNAL ARTICLE]</span><br/><span class="source" title="Diabetes, obesity &amp; metabolism">Diabetes Obes Metab 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19895637/abstract/Mid__and_high_ratio_premix_insulin_analogues:_potential_treatment_options_for_patients_with_type_2_diabetes_in_need_of_greater_postprandial_blood_glucose_control_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19895637/full_citation/Mid__and_high_ratio_premix_insulin_analogues:_potential_treatment_options_for_patients_with_type_2_diabetes_in_need_of_greater_postprandial_blood_glucose_control_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19895637/Mid__and_high_ratio_premix_insulin_analogues:_potential_treatment_options_for_patients_with_type_2_diabetes_in_need_of_greater_postprandial_blood_glucose_control_">Find Related Articles</a> </description></item><item><title>[Use of insulin glargine in type 1 diabetes children with less than eight years old]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893914/full_citation/[Use_of_insulin_glargine_in_type_1_diabetes_children_with_less_than_eight_years_old]</link><description>Rollin G, Punales M, Geremia C, et al. <br/><span class="title">[Use of insulin glargine in type 1 diabetes children with less than eight years old] [English Abstract, Journal Article]</span><br/><span class="source" title="Arquivos brasileiros de endocrinologia e metabologia">Arq Bras Endocrinol Metabol 2009 Aug; 53(6):721-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893914/abstract/[Use_of_insulin_glargine_in_type_1_diabetes_children_with_less_than_eight_years_old]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893914/full_citation/[Use_of_insulin_glargine_in_type_1_diabetes_children_with_less_than_eight_years_old]">Full Citation</a></description></item><item><title>Evaluation of the lack of anorectic effect of intracerebroventricular insulin in rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864335/full_citation/Evaluation_of_the_lack_of_anorectic_effect_of_intracerebroventricular_insulin_in_rats_</link><description>Jessen L, Clegg DJ, Bouman SD <br/><span class="title">Evaluation of the lack of anorectic effect of intracerebroventricular insulin in rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of physiology. Regulatory, integrative and comparative physiology">Am J Physiol Regul Integr Comp Physiol 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864335/abstract/Evaluation_of_the_lack_of_anorectic_effect_of_intracerebroventricular_insulin_in_rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19864335/full_citation/Evaluation_of_the_lack_of_anorectic_effect_of_intracerebroventricular_insulin_in_rats_">Full Citation</a></description></item><item><title>Structural Basis of the Aberrant Receptor Binding Properties of Hagfish and Lamprey Insulins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19863112/full_citation/Structural_Basis_of_the_Aberrant_Receptor_Binding_Properties_of_Hagfish_and_Lamprey_Insulins_</link><description>Sajid W, Holst PA, Kiselyov VV, et al. <br/><span class="title">Structural Basis of the Aberrant Receptor Binding Properties of Hagfish and Lamprey Insulins. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biochemistry">Biochemistry 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19863112/abstract/Structural_Basis_of_the_Aberrant_Receptor_Binding_Properties_of_Hagfish_and_Lamprey_Insulins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19863112/full_citation/Structural_Basis_of_the_Aberrant_Receptor_Binding_Properties_of_Hagfish_and_Lamprey_Insulins_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19863112/Structural_Basis_of_the_Aberrant_Receptor_Binding_Properties_of_Hagfish_and_Lamprey_Insulins_">Find Related Articles</a> </description></item><item><title>A robust assay measuring GLUT4 translocation in rat myoblasts overexpressing Glut4myc and AS160_v2.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19854150/full_citation/A_robust_assay_measuring_GLUT4_translocation_in_rat_myoblasts_overexpressing_Glut4myc_and_AS160_v2_</link><description>Baus D, Yan Y, Li Z, et al. <br/><span class="title">A robust assay measuring GLUT4 translocation in rat myoblasts overexpressing Glut4myc and AS160_v2. [JOURNAL ARTICLE]</span><br/><span class="source" title="Analytical biochemistry">Anal Biochem 2009 Oct 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19854150/abstract/A_robust_assay_measuring_GLUT4_translocation_in_rat_myoblasts_overexpressing_Glut4myc_and_AS160_v2_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19854150/full_citation/A_robust_assay_measuring_GLUT4_translocation_in_rat_myoblasts_overexpressing_Glut4myc_and_AS160_v2_">Full Citation</a></description></item><item><title>Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19839787/full_citation/Influence_of_polymers_ratio_on_insulin_loaded_nanoparticles_based_on_poly_epsilon_caprolactone_and_Eudragit_RS_for_oral_administration_</link><description>Socha M, Sapin A, Damgé C, et al. <br/><span class="title">Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration. [Journal Article]</span><br/><span class="source" title="Drug delivery">Drug Deliv 2009 Nov; 16(8):430-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19839787/abstract/Influence_of_polymers_ratio_on_insulin_loaded_nanoparticles_based_on_poly_epsilon_caprolactone_and_Eudragit_RS_for_oral_administration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19839787/full_citation/Influence_of_polymers_ratio_on_insulin_loaded_nanoparticles_based_on_poly_epsilon_caprolactone_and_Eudragit_RS_for_oral_administration_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19839787/Influence_of_polymers_ratio_on_insulin_loaded_nanoparticles_based_on_poly_epsilon_caprolactone_and_Eudragit_RS_for_oral_administration_">Find Related Articles</a> </description></item></channel></rss>